Bdparib 200 Mg Tablet (Rucaparib)

Bdparib 200 mg contains Rucaparib, a PARP inhibitor used to treat certain prostate and ovarian cancers. It works by blocking PARP enzymes, preventing cancer cells from repairing damaged DNA and slowing their growth. This targeted therapy may be prescribed for eligible patients based on specific genetic factors. Common side effects include nausea, fatigue, anemia, vomiting, constipation, and decreased appetite. Active Ingredient (Generic Name): Rucaparib Indication: Treatment of Prostate and Ovarian Cancers Manufacturer: BDR Pharmaceuticals Packaging: 60 Tablets in bottle Strength 200mg Delivery Time: 6 To 15 days